 concurr cisplatin infusion fluorouracil radiat therapi head neck cancer dose-limit mucos toxic preliminari dose-find studi patient advanc recurr head neck cancer patient phase II protocol fluorouracil continu intraven IV infus day sixth day IV infus cisplatin first fourth week radiat therapi total dose Gy Gy daili fraction patient american joint committe cancer stage ajcc stage iii diseas stage IV diseas recurr diseas surgeri three-year follow-up avail twenty-on treatment free local region relaps year system metastas success salvag treatment case determin surviv year acut toxic manag regim eleven instanc grade radiat therapi oncolog group/european organ research treatment cancer rtog/eortc mucos interrupt case late sequela protocol describ toler number locoregion cure convent radiotherapi group patient use infusion fluorouracil concurr radiat therapi cisplatin infus result mucos dose fluorouracil level subtherapeut